We performed a meta-analysis to estimate the odds ratio (OR) of developing PD for carriers of all pathogenic GBA1 variants plus p.E326K, and specifically for carriers of p.L444P and p.N370 variants. This evidence concerns the gene GBA1 and Parkinson disease.